A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease. (Q53287201)
Jump to navigation
Jump to search
scientific article published in April 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease. |
scientific article published in April 2007 |
Statements
A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease. (English)
1 reference
Christopher H van Dyck
1 reference
Pierre N Tariot
1 reference
Barnett Meyers
1 reference
E Malca Resnick
1 reference
Memantine MEM-MD-01 Study Group
1 reference
1 April 2007
1 reference
21
1 reference
2
1 reference
136-143
1 reference
Identifiers
1 reference